control group :oral probiotic simulant

2 trials

Sponsors

the first affiliated hospital of harbin medical university, The 1st Affiliated Hospital of He'nan University of Science and Technology

Conditions

Helicobacter Pylori infectiontype 2 diabetes

Unknown Phase

A randomised,double-blind,placebo-controlled trial,to evaluate the effects of BL21 combined with hypoglycemic agent on glycated hemoglobin and intestinal flora in T2DM patients

Active, not recruitingChiCTR2300073299

the first affiliated hospital of harbin medical universitytype 2 diabetes

Start: 2023-08-01Updated: 2023-07-10

A randomised, double-blind, placebo-controlled trial, to assess the safety and efficacy of Bacillus coagulans BC99 combined with anti-Helicobacter pylori treatment and its effect on gastric function and intestinal flora

Active, not recruitingChiCTR2300073499

The 1st Affiliated Hospital of He'nan University of Science and TechnologyHelicobacter Pylori infection

Start: 2023-08-10Updated: 2023-07-16

Related Papers

Probiotic Supplementation With <i>Bifidobacterium longum</i> Subsp. <i>Longum</i> BL21 Improves Glycemic Control and Modulates Gut Microbiota in Type 2 Diabetes: A Randomized Controlled Trial.

2026-01-09